Viewing Study NCT05327803


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2026-03-01 @ 11:20 PM
Study NCT ID: NCT05327803
Status: TERMINATED
Last Update Posted: 2025-05-08
First Post: 2022-03-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Sponsor: AN2 Therapeutics, Inc
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None MAC Lung Disease View
None Treatment Refractory MAC Lung Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NTM View
None Respiratory Infection View
None antimycobacterial activity View
None antimycobacterial agent View
None antimycobacterial therapy View
None MAC infections View
None MAC lung disease View
None MAC lung infection View
None MAC pulmonary infection View
None Mycobacteria View
None mycobacterial disease View
None mycobacterium View
None Mycobacterium Avium Complex View
None Mycobacterium Avium Complex Infections View
None Mycobacterium avium complex lung disease View
None Mycobacterium Infections View
None Nontuberculous View
None Nontuberculous mycobacteria / mycobacterial / mycobacterium View
None Non-tuberculous mycobacteria disease View
None Non-tuberculous mycobacterial (NTM) infections View
None Nontuberculous mycobacterial lung disease View
None Non-tuberculous mycobacterial lung disease View
None Nontuberculous mycobacterial pulmonary disease View
None NTM infection View
None NTM lung disease View
None NTM Pulmonary Disease View
None NTM lung infection View
None Pulmonary MAC disease View
None Pulmonary MAC lung disease View
None Pulmonary Mycobacterium Avium Complex disease View
None Treatment refractory MAC lung disease View
None Treatment refractory mycobacterial lung disease View
None Treatment refractory NTM lung disease View
None Treatment refractory NTM lung infection View
None Treatment refractory NTM pulmonary disease View